$15.79 -0.28 (-1.74%)
11/27/2009 1:00 PM

inVentiv Health, Inc. (VTIV)

CAPS Rating: 5 out of 5

The Company is a provider of value-added services to the pharmaceutical and life sciences industries.

Results 1 - 20 of 143 1 2 3 4 5 6 7 8 Next »

Recs

0
Member Avatar Forbajato (63.65) Submitted: 11/1/2009 8:04:52 AM : Outperform Start Price: $17.02 VTIV Score: -12.45

Though change is coming in health care I don't see a decrease in demand for the kind of information inVentiv provides any time soon.

Recs

0
Member Avatar jmpreiks (91.29) Submitted: 10/29/2009 1:09:35 PM : Outperform Start Price: $17.23 VTIV Score: -11.50

Good health care stock if cost cutting becomes a major goal.

Recs

0
Member Avatar artist28 (< 20) Submitted: 10/27/2009 2:23:01 PM : Outperform Start Price: $17.85 VTIV Score: -14.23

It is all in the Health Care Reform phorum. This stock along with other stock in Health Care will outperform, as new rules and procedures will be implemented in this sector.

Recs

0
Member Avatar 3DeeFool (87.19) Submitted: 10/21/2009 1:24:23 PM : Outperform Start Price: $18.79 VTIV Score: -15.74

These were recent additions of the Hidden Gems service. I'm adding these to track their performance, and evaluate the service.

Recs

0
Member Avatar NoDoughBro (70.24) Submitted: 10/16/2009 11:06:11 PM : Outperform Start Price: $17.34 VTIV Score: -8.27

I'm back!

Recs

0
Member Avatar Sandy1260 (28.62) Submitted: 10/14/2009 11:25:34 PM : Outperform Start Price: $17.73 VTIV Score: -11.67

Undisputed industry leader. Provides a broad range of key services to Pharma. They fill a need and will be well paid for it

Recs

0
Member Avatar mmacioci (74.19) Submitted: 9/30/2009 3:50:24 PM : Outperform Start Price: $16.82 VTIV Score: -9.83

low pe/ high rating but way off its low

Recs

0
Member Avatar johnnyb39 (67.89) Submitted: 9/29/2009 1:57:35 AM : Outperform Start Price: $17.23 VTIV Score: -11.23

Buy this stock now and make some money.

Recs

1
Member Avatar investorpoet2 (81.62) Submitted: 9/25/2009 10:38:20 AM : Outperform Start Price: $16.51 VTIV Score: -8.72

I'm adding InVentiv Health (VTIV) to CAPS today.

They serve the pharmaceuttical industry. Through acquisition they have added more and more services, and through cross-selling are hoping to be a one-stop shop for many companies looking to outsource some of their business functions.

InVentiv has stopped there flurry of acquisitions for now, and they are focusing on integrating the companies they hold and paying down debt. Total long-term debt was $320MM at the end of the last quarter. Large write-downs at year-end 2008 have obscured InVentiv's earnings, but the company produced $87MM in operating cash flow in 2008, and has produced $57MM in operating cash flow through the first six months of 2009. Yet today they have a market cap of $556MM. Yes, this company is priced at 6.4x 2008 cash flow and 4.9x 2009 annualized cash flow. Debt service should not be an issue.

Even if the company produces no organic growth over the next year, with their level of cash flow (which will show up on the earnings statements soon), bolt on acquisitions should commence soon, leading to higher earnings and greater value for shareholders. I look for Inventiv to trade around 12-15x operating cash flow in 2010, resulting in a share price of $40. Easily a double from here.

Recs

0
Member Avatar jpmj (< 20) Submitted: 9/22/2009 8:38:45 PM : Outperform Start Price: $17.40 VTIV Score: -11.38

took fool's advice

Recs

0
Member Avatar TMFmrquakeroats (87.30) Submitted: 9/18/2009 12:49:53 PM : Outperform Start Price: $14.17 VTIV Score: +1.34

TMF pick and rated 5 stars.

Recs

0
Member Avatar darthballs (76.66) Submitted: 9/10/2009 9:50:06 AM : Outperform Start Price: $13.69 VTIV Score: -1.71

5 star, small cap, healthcare, HG rec. Real life holding, bought after the large drop after Q2 earnings release.

Recs

1
Member Avatar nibs61 (72.13) Submitted: 9/4/2009 12:22:42 PM : Outperform Start Price: $16.01 VTIV Score: -9.64

The safest way to make money in the health group without the risk of our goverment skrewing it up.

Recs

1
Member Avatar Wakester0 (44.10) Submitted: 8/12/2009 12:55:12 PM : Outperform Start Price: $14.02 VTIV Score: +3.58

Not as comfortable on this short term as I'd like to be, with health care town-hall takedowns going on, but it's a good entry price. Once the direction of health care is figured out, one way or the other, this is a solid company that stands to do very well, and is on solid financial footing to weather the storm.

Recs

0
Member Avatar Hozer02 (65.07) Submitted: 8/11/2009 4:43:14 AM : Outperform Start Price: $13.92 VTIV Score: +3.91

Cost cutting and diversification from acquisitions providing improved efficiency and streamlining...I like it to rebound when the health reform dust settles...

Recs

0
Member Avatar PatrickDickey (28.61) Submitted: 8/10/2009 3:37:31 PM : Outperform Start Price: $13.92 VTIV Score: +3.91

I figure the SA team can't be too far off the mark.

Recs

1
Member Avatar kkconway (90.20) Submitted: 8/6/2009 2:47:25 PM : Outperform Start Price: $13.82 VTIV Score: +3.99

Down 9% today on earnings disappointment, but not a trend, rather a natural result of worldwide 2009 belt tightening. After Obamacare meets Harry and Louise and the 75% of Americans scared of socialized medicine, it will be back in business with a bullet. Hoping for a two-bagger in six months.

Recs

0
Member Avatar kevinottofro (98.38) Submitted: 8/3/2009 5:16:18 AM : Outperform Start Price: $15.63 VTIV Score: -9.20

Low relative PE, good star ranking, PEG & 09 PE still below normal - bottom fishing - 8/3 picks

Recs

0
Member Avatar fdude71 (93.80) Submitted: 7/20/2009 3:54:12 PM : Outperform Start Price: $14.65 VTIV Score: -7.05

5 CAPS Stars
PE < 7
Good balance sheet... the company is generating cash and at ~$14.5 we are buying close to book value. Should see some growth on this one.
:)

MTF HG

Recs

0
Member Avatar FAOFool (81.68) Submitted: 7/18/2009 5:34:34 AM : Outperform Start Price: $14.36 VTIV Score: -6.32

VTIV is in a great position to benefit from current political trends, as well as long-term demographic trends. I am buying shares now (Jul 09).

Featured Broker Partners